116 related articles for article (PubMed ID: 25757575)
1. Bilberry extract (Antho 50) selectively induces redox-sensitive caspase 3-related apoptosis in chronic lymphocytic leukemia cells by targeting the Bcl-2/Bad pathway.
Alhosin M; León-González AJ; Dandache I; Lelay A; Rashid SK; Kevers C; Pincemail J; Fornecker LM; Mauvieux L; Herbrecht R; Schini-Kerth VB
Sci Rep; 2015 Mar; 5():8996. PubMed ID: 25757575
[TBL] [Abstract][Full Text] [Related]
2. The BH3-only protein Noxa is stimulated during apoptosis of chronic lymphocytic leukemia cells triggered by M2YN, a new plant-derived extract.
Zaher M; Mirshahi M; Nuraliev Y; Sharofova M; Bombarda I; Marie JP; Billard C
Int J Oncol; 2011 Oct; 39(4):965-72. PubMed ID: 21750864
[TBL] [Abstract][Full Text] [Related]
3. Glycosylation of anthocyanins enhances the apoptosis of colon cancer cells by handicapping energy metabolism.
Jing N; Song J; Liu Z; Wang L; Jiang G
BMC Complement Med Ther; 2020 Oct; 20(1):312. PubMed ID: 33059637
[TBL] [Abstract][Full Text] [Related]
4. Association of reactive oxygen species-mediated signal transduction with in vitro apoptosis sensitivity in chronic lymphocytic leukemia B cells.
Palazzo AL; Evensen E; Huang YW; Cesano A; Nolan GP; Fantl WJ
PLoS One; 2011; 6(10):e24592. PubMed ID: 22016760
[TBL] [Abstract][Full Text] [Related]
5. Decreased apoptotic priming and loss of BCL-2 dependence are functional hallmarks of Richter's syndrome.
Rigo A; Vaisitti T; Laudanna C; Terrabuio E; Micillo M; Frusteri C; D'Ulivo B; Merigo F; Sbarbati A; Mellert K; Möeller P; Montresor A; Di Napoli A; Cirombella R; Butturini E; Massaia M; Constantin G; Vinante F; Deaglio S; Ferrarini I
Cell Death Dis; 2024 May; 15(5):323. PubMed ID: 38724507
[TBL] [Abstract][Full Text] [Related]
6. In Vitro Inhibitory Potential of Different Anthocyanin-Rich Berry Extracts in Murine CT26 Colon Cancer Cells.
Schmutz C; Will F; Varga E; Jaunecker C; Pahlke G; Berger W; Marko D
Molecules; 2023 Nov; 28(23):. PubMed ID: 38067418
[TBL] [Abstract][Full Text] [Related]
7. Targeting the NTSR2/TrkB oncogenic pathway in chronic lymphocytic leukemia.
Ikhlef L; Yassine M; Chandouri B; Rivière L; Naves T; Dmytruk N; Gachard N; Jauberteau MO; Gallet PF
Sci Rep; 2024 Mar; 14(1):6084. PubMed ID: 38480783
[TBL] [Abstract][Full Text] [Related]
8. Potential New Therapies "ROS-Based" in CLL: An Innovative Paradigm in the Induction of Tumor Cell Apoptosis.
Sciaccotta R; Gangemi S; Penna G; Giordano L; Pioggia G; Allegra A
Antioxidants (Basel); 2024 Apr; 13(4):. PubMed ID: 38671922
[TBL] [Abstract][Full Text] [Related]
9. H3K9 methyltransferase G9a negatively regulates UHRF1 transcription during leukemia cell differentiation.
Kim KB; Son HJ; Choi S; Hahm JY; Jung H; Baek HJ; Kook H; Hahn Y; Kook H; Seo SB
Nucleic Acids Res; 2015 Apr; 43(7):3509-23. PubMed ID: 25765655
[TBL] [Abstract][Full Text] [Related]
10. UHRF1 is a sensor for DNA interstrand crosslinks and recruits FANCD2 to initiate the Fanconi anemia pathway.
Liang CC; Zhan B; Yoshikawa Y; Haas W; Gygi SP; Cohn MA
Cell Rep; 2015 Mar; 10(12):1947-56. PubMed ID: 25801034
[TBL] [Abstract][Full Text] [Related]
11. Three newly approved drugs for chronic lymphocytic leukemia: incorporating ibrutinib, idelalisib, and obinutuzumab into clinical practice.
Sanford DS; Wierda WG; Burger JA; Keating MJ; O'Brien SM
Clin Lymphoma Myeloma Leuk; 2015 Jul; 15(7):385-91. PubMed ID: 25817936
[TBL] [Abstract][Full Text] [Related]
12. In vitro study of biological activities of anthocyanin-rich berry extracts on porcine intestinal epithelial cells.
Kšonžeková P; Mariychuk R; Eliašová A; Mudroňová D; Csank T; Király J; Marcinčáková D; Pistl J; Tkáčiková L
J Sci Food Agric; 2016 Mar; 96(4):1093-100. PubMed ID: 25801092
[TBL] [Abstract][Full Text] [Related]
13. PD-L1 checkpoint blockade prevents immune dysfunction and leukemia development in a mouse model of chronic lymphocytic leukemia.
McClanahan F; Hanna B; Miller S; Clear AJ; Lichter P; Gribben JG; Seiffert M
Blood; 2015 Jul; 126(2):203-11. PubMed ID: 25800048
[TBL] [Abstract][Full Text] [Related]
14. Nobiletin ameliorates cisplatin-induced acute kidney injury due to its anti-oxidant, anti-inflammatory and anti-apoptotic effects.
Malik S; Bhatia J; Suchal K; Gamad N; Dinda AK; Gupta YK; Arya DS
Exp Toxicol Pathol; 2015; 67(7-8):427-33. PubMed ID: 26002685
[TBL] [Abstract][Full Text] [Related]
15. Anticancer Effect of Ginger Extract against Pancreatic Cancer Cells Mainly through Reactive Oxygen Species-Mediated Autotic Cell Death.
Akimoto M; Iizuka M; Kanematsu R; Yoshida M; Takenaga K
PLoS One; 2015; 10(5):e0126605. PubMed ID: 25961833
[TBL] [Abstract][Full Text] [Related]
16. Arsenic trioxide synergistically potentiates the cytotoxic effect of fludarabine in chronic lymphocytic leukemia cells by further inactivating the Akt and ERK signaling pathways.
Lozano-Santos C; Amigo-Jiménez I; Nova-Gurumeta S; Pérez-Sanz N; García-Pardo A; García-Marco JA
Biochem Biophys Res Commun; 2015 May; 461(2):243-8. PubMed ID: 25869069
[TBL] [Abstract][Full Text] [Related]
17. Highlights in the treatment of chronic lymphocytic leukemia from the 2014 meeting of the American Society of Hematology.
Molica S
Expert Rev Hematol; 2015 Jun; 8(3):277-81. PubMed ID: 25804936
[TBL] [Abstract][Full Text] [Related]
18. The MEK1/2 inhibitor, MEKi-1, induces cell death in chronic lymphocytic leukemia cells under conditions that mimic the tumor microenvironment and is synergistic with fludarabine.
Crassini K; Stevenson WS; Mulligan SP; Best OG
Leuk Lymphoma; 2015; 56(12):3407-17. PubMed ID: 25804768
[TBL] [Abstract][Full Text] [Related]
19. Final results of EFC6663: a multicenter, international, phase 2 study of alvocidib for patients with fludarabine-refractory chronic lymphocytic leukemia.
Lanasa MC; Andritsos L; Brown JR; Gabrilove J; Caligaris-Cappio F; Ghia P; Larson RA; Kipps TJ; Leblond V; Milligan DW; Janssens A; Johnson AJ; Heerema NA; Bühler A; Stilgenbauer S; Devin J; Hallek M; Byrd JC; Grever MR
Leuk Res; 2015 May; 39(5):495-500. PubMed ID: 25804339
[TBL] [Abstract][Full Text] [Related]
20. Second cancers and Richter transformation are the leading causes of death in patients with trisomy 12 chronic lymphocytic leukemia.
Strati P; Abruzzo LV; Wierda WG; O'Brien S; Ferrajoli A; Keating MJ
Clin Lymphoma Myeloma Leuk; 2015 Jul; 15(7):420-7. PubMed ID: 25800543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
